查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854046

伽瑪刀市場按分銷管道、最終用戶、應用和產品類型分類－2025-2032年全球預測

Gamma Knife Market by Distribution Channel, End User, Application, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，伽瑪刀市場規模將達到 6.4868 億美元，複合年成長率為 7.09%。

主要市場統計數據
基準年 2024 3.7491億美元
預計年份：2025年 4.0105億美元
預測年份：2032年 6.4868億美元
複合年成長率 (%) 7.09%

本文對伽瑪刀放射線手術技術、臨床應用以及影響採購和服務模式的商業動態進行了簡明扼要的基本概述。

伽瑪刀立體定位放射放射線手術仍然是神經外科和放射外科治療模式中的基石技術，它將亞毫米級的靶向精度與非侵入性治療相結合，用於治療複雜的顱內病變。該系列設備涵蓋了傳統平台和現代平台，它們在光束傳輸架構、工作流程整合以及輔助成像和計劃軟體方面存在差異。臨床相關人員持續優先考慮那些能夠最大限度減少患者固定、最佳化治療效率並與涵蓋神經外科、放射腫瘤科和神經腫瘤科的多學科治療流程整合的系統。

在商業性，伽瑪刀系統生態系統涵蓋了與原始設備製造商 (OEM) 的直接合作協議、分銷商關係以及從三級醫院到門診手術中心等各類終端用戶。採購偏好和服務合約的趨勢反映了以結果為主導的採購模式，其中生命週期服務協議、升級路徑和軟體價值獲取等因素都會影響採購決策。本導論性概述將臨床能力、通路動態和產品演進與對醫院高階主管、服務線負責人和商業團隊至關重要的策略考量連結起來，為後續分析奠定了基礎。

臨床進步、工作流程效率提升和不斷演變的籌資策略如何重塑放射外科服務的提供者採用和供應商競爭格局

伽瑪刀治療領域正因技術創新、臨床路徑的演進和商業性模式的改變而改變。立體定位計畫演算法的進步、與高解析度磁振造影的整合以及無框架工作流程的出現，拓展了適應症範圍，改善了病患體驗，促使更多中心將放射線手術作為特定腦部病變的標準治療方案進行評估。這些臨床進展，加上治療效率和吞吐量的提升（影響治療的地點和方式），使得伽瑪刀治療得以在傳統三級醫療中心之外得到應用。

同時，競爭動態日趨成熟。各種放射學平台和影像導引系統不斷湧現，迫使傳統產品線展現差異化的臨床療效和營運經濟效益。部分地區的支付和報銷機制也更重視流程和結果，迫使供應商和醫療機構提供療效對比和資源利用率的證明。此外，隨著醫院尋求降低初始資本支出並更好地預測多年總擁有成本，籌資策略也正轉向配套服務模式和快速升級路徑。

評估累積關稅和進口限制如何影響放射線手術系統採購時間、供應商定價策略和供應鏈韌性

近期關稅政策的變化為伽瑪刀系統的資本設備規劃和供應鏈彈性帶來了新的變數。關稅的累積以及相關的進口限制會影響複雜醫療設備、組件和軟體硬體升級的到岸成本，進而對供應商的定價策略和設施採購時間產生連鎖反應。採購團隊正日益將關稅情境規劃納入資本核准流程，以確保緊急資金到位，並避免因清關和供應商重新定價而導致的計劃延誤。

為此，目標商標產品製造商和分銷商正在調整商業性策略，包括庫存本地化、關鍵零件供應商多元化，以及提供更靈活的融資和升級即服務選項。雖然長期服務協議和在地化的升級庫存可以緩解即時價格衝擊，但依賴臨時採購的機構可能面臨更大的風險。這需要重新重視供應鏈透明度、明確價格調整的合約條款，並加強採購、臨床工程和供應商客戶團隊之間的協作，以管理實施進度和預算影響。

透過精細化的細分框架，我們可以獲得可操作的洞察，該框架展示了管道、最終用戶、臨床用途和產品模型如何決定市場採納管道和售後市場需求。

詳細的細分分析揭示了不同分銷管道、最終用戶、應用領域和產品類型在產品採納促進因素和商業化管道方面的差異。分銷管道動態包括直銷模式（包括電子商務舉措和專屬OEM銷售團隊）以及透過區域和全國分銷商網路營運的經銷商主導管道，每種模式都會影響前置作業時間、服務應對力和捆綁銷售機會。最終使用者細分涵蓋了從注重簡化工作流程的門診手術中心（包括放射科和外科中心）到擁有綜合多學科計畫的區域性和三級醫療中心，再到優先考慮特定手術吞吐量和臨床結果的專科診所（例如神經外科中心和腫瘤科診所）。

基於應用領域的細分突出了腦腫瘤治療（區分原發性和轉移性病變）、功能性疾病（如運動障礙和三叉神經痛）以及血管畸形（包括動靜脈畸形和海綿狀血管畸形）等方面的獨特臨床和操作考慮。產品類型細分則反映了傳統平台和新型平台的裝機量和升級管道，例如4C、Icon、Model C和Perfexion等型號，每種型號都提供新的機器類型銷售和升級方案，因此具有不同的裝置量模式。

區域法律規範、報銷動態和醫療服務提供者基礎設施的差異如何影響全球主要地區的採用模式和商業性模式

伽瑪刀系統的臨床應用模式、法規要求和商業性實施深受區域動態的影響。在美洲，大型學術醫療中心和區域醫院系統並存，其報銷機制和網路層面的資本規劃決定了升級和新設備的部署速度。在手術報銷和患者吞吐量支援分散式放射放射線手術服務的地區，門診治療模式正日益普及。同時，都市區三級醫療中心仍在持續投資於綜合多重模式治療計畫。

在歐洲、中東和非洲，法律規範和國家報銷政策造成了營運環境的差異，靈活的商業模式和強大的經銷商合作夥伴關係更受青睞，以便應對當地的核准和服務預期。在一些國家，公共醫療採購流程和集中競標要求提供令人信服的臨床和成本效益證據。在亞太地區，主要城市中心的產能快速擴張與新興市場的定向投資結合。事實證明，本地製造夥伴關係、培訓計畫和可擴展的服務模式能夠有效加速產品推廣，同時應對勞動力和基礎設施的差異。

為什麼產品差異化、卓越的全生命週期服務和通路夥伴關係決定了放射線手術領域的競爭優勢和長期供應商合作關係

在伽瑪刀及更廣泛的立體定位放射線手術市場中，競爭地位取決於產品差異化、全生命週期服務能力和通路執行力的綜合考量。領先供應商專注於展示臨床精準性、工作流程整合性和長期可維護性，而相鄰的競爭對手則致力於提供替代的射線束傳輸技術和混合治療方案，以吸引那些尋求多功能平台的醫療機構。原始設備製造商 (OEM) 與醫院系統之間的策略夥伴關係日益重視已安裝設備的升級、培訓以及軟體驅動的臨床決策支持，以此作為維持長期合作關係的手段。

除了主要製造商之外，服務供應商、影像處理合作夥伴和軟體開發商組成的網路在實現臨床價值方面也發揮著至關重要的作用。投資於完善的培訓體系、遠端監控功能和快速的零件供應的公司，能夠從已安裝的系統中挖掘更多價值，並減少醫療機構的停機時間。此外，為 4C、Icon、Model C 和 Perfexion 等型號提供清晰升級路徑的原始設備製造商 (OEM) 和經銷商，可延長設備的使用壽命，並提供更可預測的總成本。

供應商和服務商可採取切實可行的策略步驟，協調產品創新、商業性靈活性和服務能力，以加速產品推廣應用並降低實施風險。

產業領導者應採取多管齊下的策略，在應對臨床、商業性和政策方面的挑戰的同時，抓住放射線手術的成長機會。首先，產品藍圖與臨床醫生的需求保持一致，優先考慮無框架工作流程、增強影像整合和自動化規劃，以縮短治療時間並擴大患者覆蓋範圍。持續投資於臨床證據的產生和同儕審查的結果數據，能夠增強採購論證，並支持將其納入標準化診療路徑。

其次，我們將最佳化商業模式，降低關稅帶來的成本波動，並透過拓展靈活的資金籌措、升級即服務 (UaaS) 和本地化庫存策略來縮短部署週期。加強通路夥伴關係：明確直銷團隊和各國分銷商之間的角色分工，以確保服務水準協議的一致性和知識轉移的順利進行。最後，我們將投資於員工賦能和數位化服務能力，例如遠端診斷和培訓平台，以提高運作，支援新用戶快速上手，並加強與客戶的長期合作關係。

採用透明的混合方法研究途徑，結合相關人員訪談和二手證據綜合，以檢驗臨床和商業性見解。

本分析綜合運用混合研究途徑，結合了對主要相關利益者的訪談和嚴謹的二手證據綜合分析，從而得出相關見解。主要訪談包括與臨床負責人、採購專家、臨床工程師和供應商客戶經理進行結構化訪談和討論，以了解他們對設備選擇標準、工作流程優先順序和合約偏好的現場觀點。這些對話使我們對不同類型醫療機構在實施過程中遇到的障礙、服務期望和升級理由有了定性的了解。

二級研究涵蓋了同行評審的臨床文獻、監管指南、政策公告和公開的產品文​​檔，旨在檢驗臨床性能聲明，並將技術發展置於監管框架內進行考察。調查方法包括對一手和二手資料進行交叉檢驗，以識別共同的主題並確定需要密切關注的領域。透過迭代三角驗證來保持分析的嚴謹性，確保結論能夠反映在多個資訊流和相關人員中觀察到的一致模式。

一份綜合總結報告，重點闡述了策略重點、供應鏈韌性和證據完整性，以支持永續放射放射線手術的推廣應用。

最後，伽瑪刀領域正處於曲折點，臨床創新、供應鏈動態和不斷演變的採購模式在此交會。積極適應無框架工作流程、投資於可互通的規劃和成像解決方案並部署靈活商業模式的醫療服務提供者和供應商，將更有利於抓住新的市場需求並加強長期夥伴關係。關稅帶來的成本壓力凸顯了供應鏈多元化和本地服務能力的重要性，以確保實施時間表和總生命週期成本的可預測性。

展望未來，成功與否取決於臨床證據產生與採購方案的契合度、利用細分市場洞察來調整通路和產品策略，以及建構能夠保障系統運作並維繫臨床醫師忠誠度的穩健服務基礎設施。將這些因素納入資本規劃和臨床策略的醫療機構，將更有利於擴大精準放射放射線手術的覆蓋範圍，同時保持財務紀律和卓越運作。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 提高無框架立體定位放射外科技術的應用，以提高病患舒適度和工作流程效率
  • 整合人工智慧演算法以實現即時劑量計劃和自適應治療最佳化
  • 擴大伽瑪刀的適應症範圍，將三叉神經痛等非惡性神經系統疾病納入其中。
  • 開發聚焦光束准直技術，以減少健康腦組織受到的輻射暴露
  • 由於成本更低、恢復時間更短，門診放射線手術越來越受到青睞。
  • 學術中心與製造商合作進行的一項研究舉措，旨在提高精準放射放射線手術的效果。
  • 監管核准和報銷改革促進新興市場更廣泛地獲得伽瑪刀治療

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 伽瑪刀市場依分銷管道分類

  • 直銷
    • 電子商務
    • OEM銷售團隊
  • 批發商
    • 當地經銷商
    • 全國經銷商

9. 以最終用戶分類的伽瑪刀市場

  • 門診手術中心
    • 放射中心
    • 手術中心
  • 醫院
    • 社區醫院
    • 三級醫療機構
  • 專科診所
    • 神經外科中心
    • 腫瘤診所

第10章 伽瑪刀市場依應用領域分類

  • 腦腫瘤
    • 轉移性腦瘤
    • 原發性腦腫瘤
  • 功能障礙
    • 運動障礙
    • 三叉神經痛
  • 血管畸形
    • 動靜脈畸形
    • 海綿狀血管畸形

第11章 伽瑪刀市場依產品類型分類

  • 4C
    • 新單元
    • 升級
  • Icon
    • 新單元
    • 升級
  • Model C
    • 新單元
    • 升級
  • Perfexion
    • 新單元
    • 升級

第12章 伽瑪刀市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 伽瑪刀市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國伽瑪刀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Elekta AB（publ）
    • Accuray Incorporated
    • Siemens Healthineers AG
    • Varian Medical Systems, Inc.
    • Brainlab AG
    • ViewRay, Inc.
    • Nordion Inc.
    • Mevion Medical Systems, Inc.
    • IBA Group SA
    • Shinva Medical Instrument Co., Ltd.
Product Code: MRR-0D217D5AEF01

The Gamma Knife Market is projected to grow by USD 648.68 million at a CAGR of 7.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 374.91 million
Estimated Year [2025] USD 401.05 million
Forecast Year [2032] USD 648.68 million
CAGR (%) 7.09%

A concise foundational overview of Gamma Knife radiosurgery technology, clinical integration, and commercial dynamics shaping procurement and service models

Gamma Knife stereotactic radiosurgery remains a cornerstone technology in neurosurgical and radiosurgical treatment paradigms, combining sub-millimeter targeting precision with non-invasive delivery to treat complex intracranial pathologies. The device family encompasses legacy and modern platforms that vary by beam delivery architecture, workflow integration, and ancillary imaging and planning software. Clinical stakeholders continue to prioritize systems that minimize patient immobilization, optimize throughput, and integrate with multidisciplinary care pathways spanning neurosurgery, radiation oncology and neuro-oncology.

Commercially, the ecosystem around Gamma Knife systems includes direct OEM engagements, distributor relationships, and diverse end users ranging from tertiary hospitals to ambulatory surgical centers. Shifts in purchasing preferences and service contracting reflect a broader trend toward outcomes-driven procurement, where lifecycle service agreements, upgrade pathways and software-enabled value capture influence acquisition decisions. This introductory synthesis frames the subsequent analysis by linking clinical capability, channel dynamics and product evolution to the strategic considerations that matter to hospital executives, service line leaders and commercial teams.

How clinical advances, workflow efficiencies, and evolving procurement strategies are reshaping provider adoption and vendor competition in radiosurgical services

The Gamma Knife landscape is undergoing transformative shifts driven by technological innovation, evolving clinical pathways and changing commercial arrangements. Advances in stereotactic planning algorithms, integration with high-resolution MRI and the emergence of frameless workflows have broadened indications and improved patient experience, prompting more institutions to evaluate radiosurgery as a standard-of-care option for select brain lesions. These clinical advances have coincided with improvements in throughput and efficiency that influence where and how care is delivered, enabling adoption beyond traditional tertiary centers.

At the same time, competitive dynamics have matured. Competing radiation platforms and image-guided systems have intensified pressure on legacy product lines to demonstrate differentiated clinical outcomes and operational economics. Payment and reimbursement frameworks in several jurisdictions are becoming more procedure- and outcome-focused, compelling vendors and providers to document comparative effectiveness and resource utilization. Additionally, procurement strategies are shifting toward bundled service models and upgrade-first pathways, as hospitals seek to reduce large upfront capital expenditures and better predict total cost of ownership over multi-year horizons.

Assessing how cumulative tariff measures and import controls are influencing procurement timing, vendor pricing strategies, and supply chain resilience for radiosurgery systems

Recent tariff policy developments have introduced a new variable into capital equipment planning and supply chain resilience for Gamma Knife systems. Cumulative duties and associated import controls can affect the landed cost of complex medical devices, componentry and software-linked hardware upgrades, with ripple effects on vendor pricing strategies and institutional procurement timing. Procurement teams are increasingly incorporating tariff scenario planning into their capital approval processes to ensure contingency funding and avoid project delays tied to customs clearance or supplier repricing.

In response, original equipment manufacturers and distributors are adjusting their commercial approaches by localizing inventories, diversifying supplier bases for critical components and offering more flexible financing or upgrade-as-a-service arrangements. Transmission of tariff-related cost pressures to end users varies by contracting structure; long-term service agreements and locally stocked upgrade inventories can mitigate immediate price shocks, while institutions relying on ad-hoc purchasing may experience greater exposure. The combined effect is a re-emphasis on supply chain transparency, contractual clarity on price adjustments and enhanced collaboration between procurement, clinical engineering and vendor account teams to manage implementation timelines and budgetary impact.

Actionable insights from a granular segmentation framework showing how channels, end users, clinical applications, and product models determine adoption pathways and aftermarket demand

Deep segmentation analysis reveals differentiated adoption drivers and commercialization pathways across distribution channels, end users, applications and product types. Distribution channel dynamics include direct sales models, which encompass e-commerce initiatives and dedicated OEM sales teams, and distributor-led channels that operate through local and national distributor networks; each approach affects lead times, service responsiveness and opportunities for bundled offerings. End user segmentation captures a spectrum from ambulatory surgical centers, which include radiology and surgical centers focused on streamlined workflows, to hospitals that span community facilities and tertiary care centers with comprehensive multidisciplinary programs, and specialty clinics such as neurosurgery centers and oncology clinics that prioritize procedure-specific throughput and clinical outcomes.

Application-based segmentation shows distinct clinical and operational considerations for treating brain tumors-differentiating between primary and metastatic lesions-functional disorders such as movement disorders and trigeminal neuralgia, and vascular malformations including arteriovenous and cavernous variants; each indication drives unique planning protocols, imaging requirements and patient selection criteria. Product type segmentation reflects the installed base and upgrade pathways across legacy and modern platforms, with distinct purchase patterns for models including 4C, Icon, Model C and Perfexion, each offering new unit sales and upgrade packages; the interplay between available upgrades and end-user operational priorities significantly shapes replacement cycles and aftermarket service demand.

How regional regulatory frameworks, reimbursement dynamics, and provider infrastructure differences are shaping adoption patterns and commercial approaches across major global regions

Regional dynamics materially influence clinical adoption models, regulatory requirements and commercial execution for Gamma Knife systems. In the Americas, procurement decisions are shaped by a mix of large academic medical centers and community hospital systems, where reimbursement structures and network-level capital planning determine the cadence of upgrades and new installations. Transition to ambulatory settings is gaining traction where procedural reimbursement and patient throughput support decentralized radiosurgery delivery, while urban tertiary centers continue to invest in integrated multimodality programs.

In Europe, the Middle East and Africa, regulatory frameworks and national reimbursement policies create a heterogeneous operating environment that favors flexible commercial models and strong distributor partnerships to navigate local approvals and service expectations. Public healthcare procurement processes and centralized tendering in several countries necessitate compelling clinical and cost-effectiveness evidence. Asia-Pacific regions present a combination of rapid capacity expansion in major metropolitan centers and targeted investments in emerging markets; local manufacturing partnerships, training programs and scalable service models are proving effective to accelerate adoption while addressing workforce and infrastructure variability.

Why product differentiation, lifecycle service excellence, and channel partnerships determine competitive advantage and long-term vendor-provider alignment in radiosurgery

Competitive positioning within the Gamma Knife and broader stereotactic radiosurgery market depends on a combination of product differentiation, lifecycle service capabilities and channel execution. Leading vendors focus on demonstrating clinical precision, workflow integration and long-term serviceability, while adjacent competitors emphasize alternative beam delivery technologies and hybrid treatment offerings that appeal to centers seeking multifunctional platforms. Strategic partnerships between OEMs and hospital systems increasingly emphasize installed-base upgrades, training and software-enabled clinical decision support as levers to sustain long-term relationships.

Beyond headline manufacturers, a network of service providers, imaging partners and software developers plays a crucial role in enabling clinical value. Companies that invest in robust training ecosystems, remote monitoring capabilities and rapid parts distribution can extract additional value from installed systems and reduce downtime for providers. Additionally, OEMs and distributors that offer clear upgrade pathways for models like 4C, Icon, Model C and Perfexion can extend equipment lifecycles and offer more predictable total cost profiles, making their offerings more attractive to fiscally conservative procurement teams.

Practical strategic measures for vendors and providers to align product innovation, commercial flexibility, and service capability to accelerate adoption and mitigate policy risks

Industry leaders should adopt a multi-pronged strategy to navigate clinical, commercial and policy headwinds while capturing growth opportunities in radiosurgery. First, align product roadmaps with clinician needs by prioritizing frameless workflows, enhanced imaging integration and planning automation that reduce treatment times and expand eligible patient populations. Investing in continuous clinical evidence generation and peer-reviewed outcome data will strengthen procurement narratives and support inclusion in standardized care pathways.

Second, optimize commercial models by expanding flexible financing, upgrade-as-a-service offerings and localized inventory strategies to mitigate tariff-driven cost volatility and shorten implementation timelines. Strengthen channel partnerships by defining clear roles for direct sales teams versus local and national distributors, ensuring consistent service level agreements and knowledge transfer. Finally, invest in workforce enablement and digital service capabilities such as remote diagnostics and training platforms to improve uptime, support faster onboarding of new users and reinforce long-term customer relationships.

A transparent mixed-methods research approach combining stakeholder interviews and secondary evidence synthesis to validate clinical and commercial insights

This analysis synthesizes insights derived from a mixed-methods research approach that blends primary stakeholder engagement with rigorous secondary evidence synthesis. Primary engagement included structured interviews and discussions with clinical leaders, procurement specialists, clinical engineers and vendor account executives to capture frontline perspectives on device selection criteria, workflow priorities and contractual preferences. These conversations informed qualitative understanding of adoption barriers, service expectations and upgrade rationales across different facility types.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, policy announcements and publicly available product documentation to validate clinical performance claims and situate technology evolution within regulatory contexts. The methodology incorporated cross-validation between primary insights and secondary sources to identify convergent themes and to flag areas requiring closer monitoring. Analytical rigor was maintained through iterative triangulation, ensuring that conclusions reflect consistent patterns observed across multiple information streams and stakeholder groups.

A consolidated closing synthesis highlighting strategic priorities, supply chain resilience, and evidence alignment to support sustainable radiosurgery adoption

In closing, the Gamma Knife domain is at an inflection point where clinical innovation, supply chain dynamics and evolving procurement models intersect. Providers and vendors that proactively adapt to frameless workflows, invest in interoperable planning and imaging solutions, and deploy flexible commercial models will be better positioned to capture emerging demand and strengthen long-term partnerships. Tariff-induced cost pressures underscore the importance of supply chain diversification and local service capabilities to preserve implementation timelines and predictability of total lifecycle costs.

Looking ahead, success will hinge on aligning clinical evidence generation with procurement narratives, leveraging segmentation insights to tailor channel and product strategies, and building resilient service infrastructures that keep systems operational and clinicians confident. Institutions that integrate these considerations into capital planning and clinical strategy will be well-equipped to expand access to precision radiosurgery while maintaining fiscal discipline and operational excellence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of frameless stereotactic techniques to improve patient comfort and workflow efficiency
  • 5.2. Integration of artificial intelligence algorithms for real time dose planning and adaptive treatment optimization
  • 5.3. Expansion of gamma knife indications to include non malignant neurological disorders such as trigeminal neuralgia
  • 5.4. Development of focused beam collimation technologies to reduce radiation exposure to healthy brain tissue
  • 5.5. Growing preference for outpatient gamma knife radiosurgery due to cost reduction and shorter recovery times
  • 5.6. Collaborative research initiatives between academic centers and manufacturers to advance precision radiosurgery outcomes
  • 5.7. Regulatory approvals and reimbursement reforms facilitating wider gamma knife access in emerging markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gamma Knife Market, by Distribution Channel

  • 8.1. Direct Sales
    • 8.1.1. E Commerce
    • 8.1.2. Oem Sales Team
  • 8.2. Distributor
    • 8.2.1. Local Distributors
    • 8.2.2. National Distributors

9. Gamma Knife Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Radiology Centers
    • 9.1.2. Surgical Centers
  • 9.2. Hospitals
    • 9.2.1. Community Hospitals
    • 9.2.2. Tertiary Care Hospitals
  • 9.3. Specialty Clinics
    • 9.3.1. Neurosurgery Centers
    • 9.3.2. Oncology Clinics

10. Gamma Knife Market, by Application

  • 10.1. Brain Tumors
    • 10.1.1. Metastatic Brain Tumors
    • 10.1.2. Primary Brain Tumors
  • 10.2. Functional Disorders
    • 10.2.1. Movement Disorders
    • 10.2.2. Trigeminal Neuralgia
  • 10.3. Vascular Malformations
    • 10.3.1. Arteriovenous Malformations
    • 10.3.2. Cavernous Malformations

11. Gamma Knife Market, by Product Type

  • 11.1. 4C
    • 11.1.1. New Units
    • 11.1.2. Upgrades
  • 11.2. Icon
    • 11.2.1. New Units
    • 11.2.2. Upgrades
  • 11.3. Model C
    • 11.3.1. New Units
    • 11.3.2. Upgrades
  • 11.4. Perfexion
    • 11.4.1. New Units
    • 11.4.2. Upgrades

12. Gamma Knife Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gamma Knife Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gamma Knife Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Elekta AB (publ)
    • 15.3.2. Accuray Incorporated
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. Varian Medical Systems, Inc.
    • 15.3.5. Brainlab AG
    • 15.3.6. ViewRay, Inc.
    • 15.3.7. Nordion Inc.
    • 15.3.8. Mevion Medical Systems, Inc.
    • 15.3.9. IBA Group S.A.
    • 15.3.10. Shinva Medical Instrument Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GAMMA KNIFE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GAMMA KNIFE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GAMMA KNIFE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GAMMA KNIFE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 337. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 338. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 339. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 342. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 343. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 344. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 345. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 346. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 347. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 350. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 351. LATIN AMERICA GAMMA KNIFE MARKET SI